Cancer Research reagents
Cancer Antigen CA19-9 (Gastrointestinal Cancer) (Biotin) |
|||
| MBS6127299-01mL | MyBiosource | 0.1(mL | EUR 1060 |
Cancer Antigen CA19-9 (Gastrointestinal Cancer) (Biotin) |
|||
| MBS6127299-5x01mL | MyBiosource | 5x0.1mL | EUR 4615 |
Cancer Antigen CA125 (Ovarian Cancer) Partially Purified |
|||
| MBS313427-100KUnits | MyBiosource | 100KUnits | EUR 1235 |
Cancer Antigen CA125 (Ovarian Cancer) Partially Purified |
|||
| MBS313427-5x100KUnits | MyBiosource | 5x100KUnits | EUR 5380 |
CA125 Cancer Antigen, A Domain (Ovarian Cancer) (AP) |
|||
| MBS6126051-01mL | MyBiosource | 0.1(mL | EUR 1350 |
CA125 Cancer Antigen, A Domain (Ovarian Cancer) (AP) |
|||
| MBS6126051-5x01mL | MyBiosource | 5x0.1mL | EUR 5920 |
CA125 Cancer Antigen, B Domain (Ovarian Cancer) (AP) |
|||
| MBS6126052-01mL | MyBiosource | 0.1(mL | EUR 1350 |
CA125 Cancer Antigen, B Domain (Ovarian Cancer) (AP) |
|||
| MBS6126052-5x01mL | MyBiosource | 5x0.1mL | EUR 5920 |
CA125 Cancer Antigen, A Domain (Ovarian Cancer) (PE) |
|||
| MBS6129145-01mL | MyBiosource | 0.1(mL | EUR 1350 |
CA125 Cancer Antigen, A Domain (Ovarian Cancer) (PE) |
|||
| MBS6129145-5x01mL | MyBiosource | 5x0.1mL | EUR 5920 |
CA125 Cancer Antigen, B Domain (Ovarian Cancer) (PE) |
|||
| MBS6129146-01mL | MyBiosource | 0.1(mL | EUR 1350 |
CA125 Cancer Antigen, B Domain (Ovarian Cancer) (PE) |
|||
| MBS6129146-5x01mL | MyBiosource | 5x0.1mL | EUR 5920 |
Lung cancer |
|||
| LC751 | TissueArray | each | EUR 234 |
|
Description: Lung cancer, matched cancer adjacent and normal adjacent lung tissue array, including pathology grade, TNM and clinical stage (AJCC 8.0), 25 cases/75 cores (core size 1.5mm),Recent Year Collection |
|||
CA125 Cancer Antigen, A Domain (Ovarian Cancer) (HRP) |
|||
| MBS6128524-01mL | MyBiosource | 0.1(mL | EUR 1350 |
CA125 Cancer Antigen, A Domain (Ovarian Cancer) (HRP) |
|||
| MBS6128524-5x01mL | MyBiosource | 5x0.1mL | EUR 5920 |
CA125 Cancer Antigen, B Domain (Ovarian Cancer) (HRP) |
|||
| MBS6128525-01mL | MyBiosource | 0.1(mL | EUR 1350 |
CA125 Cancer Antigen, B Domain (Ovarian Cancer) (HRP) |
|||
| MBS6128525-5x01mL | MyBiosource | 5x0.1mL | EUR 5920 |
CA125 Cancer Antigen, A Domain (Ovarian Cancer) (APC) |
|||
| MBS6126669-01mL | MyBiosource | 0.1(mL | EUR 1350 |
CA125 Cancer Antigen, A Domain (Ovarian Cancer) (APC) |
|||
| MBS6126669-5x01mL | MyBiosource | 5x0.1mL | EUR 5920 |
CA125 Cancer Antigen, B Domain (Ovarian Cancer) (APC) |
|||
| MBS6126670-01mL | MyBiosource | 0.1(mL | EUR 1350 |
CA125 Cancer Antigen, B Domain (Ovarian Cancer) (APC) |
|||
| MBS6126670-5x01mL | MyBiosource | 5x0.1mL | EUR 5920 |
Cancer Antigen Antibody (CA19-9) (Gastrointestinal Cancer) |
|||
| GWB-T00219 | GenWay Biotech | 1 mg | Ask for price |
CA125 Cancer Antigen, A Domain (Ovarian Cancer) (FITC) |
|||
| MBS6127908-01mL | MyBiosource | 0.1(mL | EUR 1350 |
CA125 Cancer Antigen, A Domain (Ovarian Cancer) (FITC) |
|||
| MBS6127908-5x01mL | MyBiosource | 5x0.1mL | EUR 5920 |
CA125 Cancer Antigen, B Domain (Ovarian Cancer) (FITC) |
|||
| MBS6127909-01mL | MyBiosource | 0.1(mL | EUR 1350 |
CA125 Cancer Antigen, B Domain (Ovarian Cancer) (FITC) |
|||
| MBS6127909-5x01mL | MyBiosource | 5x0.1mL | EUR 5920 |
CA19-9 (Cancer, Cancer antigen 19-9, CA199) (AP) |
|||
| MBS6260446-01mL | MyBiosource | 0.1mL | EUR 1085 |
CA19-9 (Cancer, Cancer antigen 19-9, CA199) (AP) |
|||
| MBS6260446-5x01mL | MyBiosource | 5x0.1mL | EUR 4725 |
CA19-9 (Cancer, Cancer antigen 19-9, CA199) (PE) |
|||
| MBS6262997-01mL | MyBiosource | 0.1mL | EUR 1085 |
CA19-9 (Cancer, Cancer antigen 19-9, CA199) (PE) |
|||
| MBS6262997-5x01mL | MyBiosource | 5x0.1mL | EUR 4725 |
Liver cancer |
|||
| BC03117 | TissueArray | each | EUR 306 |
|
Description: Liver cancer, liver cirrhosis tissue array with normal tissue as control, including TNM, clinical stage, pathology grade and history of hepatitis, 70 cases/ 80 cores, replaced by BC03117a |
|||
CA19-9 (Cancer, Cancer antigen 19-9, CA199) (HRP) |
|||
| MBS6262486-01mL | MyBiosource | 0.1mL | EUR 1085 |
CA19-9 (Cancer, Cancer antigen 19-9, CA199) (HRP) |
|||
| MBS6262486-5x01mL | MyBiosource | 5x0.1mL | EUR 4725 |
CA19-9 (Cancer, Cancer antigen 19-9, CA199) (APC) |
|||
| MBS6260957-01mL | MyBiosource | 0.1mL | EUR 1085 |
CA19-9 (Cancer, Cancer antigen 19-9, CA199) (APC) |
|||
| MBS6260957-5x01mL | MyBiosource | 5x0.1mL | EUR 4725 |
CA125 Cancer Antigen (Ovarian Cancer) (PE) (Glycerol Free) |
|||
| MBS6120707-01mL | MyBiosource | 0.1(mL | EUR 680 |
CA125 Cancer Antigen (Ovarian Cancer) (PE) (Glycerol Free) |
|||
| MBS6120707-05mL | MyBiosource | 0.5mL | EUR 1145 |
CA125 Cancer Antigen (Ovarian Cancer) (PE) (Glycerol Free) |
|||
| MBS6120707-5x05mL | MyBiosource | 5x0.5mL | EUR 4990 |
CA125 Cancer Antigen, A Domain (Ovarian Cancer) (Biotin) |
|||
| MBS6127289-01mL | MyBiosource | 0.1(mL | EUR 1350 |
CA125 Cancer Antigen, A Domain (Ovarian Cancer) (Biotin) |
|||
| MBS6127289-5x01mL | MyBiosource | 5x0.1mL | EUR 5920 |
CA125 Cancer Antigen, B Domain (Ovarian Cancer) (Biotin) |
|||
| MBS6127290-01mL | MyBiosource | 0.1(mL | EUR 1350 |
CA125 Cancer Antigen, B Domain (Ovarian Cancer) (Biotin) |
|||
| MBS6127290-5x01mL | MyBiosource | 5x0.1mL | EUR 5920 |
CA125 Cancer Antigen (Ovarian Cancer) (Glycerol Free) (AP) |
|||
| MBS6260254-01mL | MyBiosource | 0.1mL | EUR 970 |
CA125 Cancer Antigen (Ovarian Cancer) (Glycerol Free) (AP) |
|||
| MBS6260254-5x01mL | MyBiosource | 5x0.1mL | EUR 4220 |
CA125 Cancer Antigen (Ovarian Cancer) (Glycerol Free) (PE) |
|||
| MBS6262805-01mL | MyBiosource | 0.1mL | EUR 970 |
CA125 Cancer Antigen (Ovarian Cancer) (Glycerol Free) (PE) |
|||
| MBS6262805-5x01mL | MyBiosource | 5x0.1mL | EUR 4220 |
Breast cancer |
|||
| BR1008b | TissueArray | each | EUR 306 |
|
Description: Breast cancer, lymph node metastatic carcinoma and adjacent normal tissue array, including pathology grade, TNM, clinical stage, and ER/PR/Her2 result, 100 cases/100 cores, replacing BR1008a |
|||
Breast cancer |
|||
| BR724 | TissueArray | each | EUR 270 |
|
Description: Breast cancer, adjacent and adjacent normal tissue array, 66 cases/72 cores |
|||
Breast cancer |
|||
| BR725 | TissueArray | each | EUR 270 |
|
Description: Breast cancer, adjacent and adjacent normal tissue array, 68 cases/72 cores |
|||
CA19-9 (Cancer, Cancer antigen 19-9, CA199) (FITC) |
|||
| MBS6261976-01mL | MyBiosource | 0.1mL | EUR 1085 |
CA19-9 (Cancer, Cancer antigen 19-9, CA199) (FITC) |
|||
| MBS6261976-5x01mL | MyBiosource | 5x0.1mL | EUR 4725 |
CA125 Cancer Antigen (Ovarian Cancer) (Glycerol Free) (HRP) |
|||
| MBS6262295-01mL | MyBiosource | 0.1mL | EUR 970 |
CA125 Cancer Antigen (Ovarian Cancer) (Glycerol Free) (HRP) |
|||
| MBS6262295-5x01mL | MyBiosource | 5x0.1mL | EUR 4220 |
CA125 Cancer Antigen (Ovarian Cancer) (Glycerol Free) (APC) |
|||
| MBS6260765-01mL | MyBiosource | 0.1mL | EUR 970 |
CA125 Cancer Antigen (Ovarian Cancer) (Glycerol Free) (APC) |
|||
| MBS6260765-5x01mL | MyBiosource | 5x0.1mL | EUR 4220 |
Breast cancer with cancer adjacent breast tissue array |
|||
| BC081116e | TissueArray | each | EUR 306 |
|
Description: Breast cancer with cancer adjacent breast tissue array, including invasive carcinoma of no special type, breast carcinoma with apocrine differentiation and AT tissue,pat hology grade, IHC (ER/PR/Her-2/Ki67) info, TNM/Stage (AJCC 7th edition), 107 cases/110 cores (core size 1.5mm), replacing BC081116d |
|||
Cervix cancer tissue array with cancer adjacent tissue |
|||
| CR501a | TissueArray | each | EUR 234 |
|
Description: Cervix cancer tissue array with cancer adjacent tissue, including TNM, clinical stage and pathology grade, 50 cases/50 cores, replacing CR501 |
|||
CA125 Cancer Antigen (Ovarian Cancer) (Glycerol Free) (FITC) |
|||
| MBS6261784-01mL | MyBiosource | 0.1mL | EUR 970 |
CA125 Cancer Antigen (Ovarian Cancer) (Glycerol Free) (FITC) |
|||
| MBS6261784-5x01mL | MyBiosource | 5x0.1mL | EUR 4220 |
Stomach cancer |
|||
| ST1451a | TissueArray | each | EUR 540 |
|
Description: Stomach cancer, matched NAT, matched metastasis tissue (recent year collection samples), including pathology grade, TNM and clinical stage, 71 cases/145 cores, replacing ST1451 |
|||
CA19-9 (Cancer, Cancer antigen 19-9, CA199) (Biotin) |
|||
| MBS6261468-01mL | MyBiosource | 0.1mL | EUR 1085 |
CA19-9 (Cancer, Cancer antigen 19-9, CA199) (Biotin) |
|||
| MBS6261468-5x01mL | MyBiosource | 5x0.1mL | EUR 4725 |
Human Cancer PrimaCell15: Skin Cancer Cells Growth Medium |
|||
| 9-46038 | CHI Scientific | 5 x 100 ml | Ask for price |
Stomach cancer with matched cancer adjacent tissue array |
|||
| ST1504 | TissueArray | each | EUR 258 |
|
Description: Stomach cancer with matched cancer adjacent tissue array, including pathology grade, TNM and clinical stage, 50 cases/150 cores |
|||
CA125 Cancer Antigen (Ovarian Cancer) (Glycerol Free) (Biotin) |
|||
| MBS6261276-01mL | MyBiosource | 0.1mL | EUR 970 |
CA125 Cancer Antigen (Ovarian Cancer) (Glycerol Free) (Biotin) |
|||
| MBS6261276-5x01mL | MyBiosource | 5x0.1mL | EUR 4220 |
Prostate cancer |
|||
| PR632 | TissueArray | each | EUR 306 |
|
Description: Prostate cancer, hyperplasia with normal tissue array, including pathology grade, Gleason grade, Gleason score, TNM and clinical stage, 21cases/63 cores |
|||
Prostate cancer tissue array with cancer adjacent tissues |
|||
| PR721 | TissueArray | each | EUR 306 |
|
Description: Prostate cancer tissue array with cancer adjacent tissues, including WHO grade, gleason grade, gleason score, TNM and stage info, 24 cases/72 cores |
|||
Pancreatic cancer tissue array with cancer adjacent tissue |
|||
| PA242e | TissueArray | each | EUR 66 |
|
Description: Pancreatic cancer tissue array with cancer adjacent tissue, including pathology grade, TNM and clinical stage, 12 cases/24 cores, replacing PA242d |
|||
Esophagus cancer |
|||
| ES1041 | TissueArray | each | EUR 306 |
|
Description: Esophagus cancer, cancer adjacent and normal esophagus tissue array, including squamous cell carcinoma,adenocarcinoma,undifferentiated carcinoma, AT and normal tissue, pathology grade, TNM and clinical stage (AJCC 8.0), 104 cases/104 cores (core size 1.5mm), replacing ES1021 |
|||
Colorectal cancer |
|||
| CRM1501 | TissueArray | each | EUR 420 |
|
Description: Colorectal cancer, 150 cases. |
|||
Cancer Antigen 19-9 (Gastrointestinal Cancer) Calibrator Grade |
|||
| MBS319684-50KUnits | MyBiosource | 50KUnits | EUR 440 |
Cancer Antigen 19-9 (Gastrointestinal Cancer) Calibrator Grade |
|||
| MBS319684-5x50KUnits | MyBiosource | 5x50KUnits | EUR 1800 |
Cancer Antigen 19-9 (Gastrointestinal Cancer) Calibrator Grade |
|||
| MBS319694-50KUnits | MyBiosource | 50KUnits | EUR 515 |
Cancer Antigen 19-9 (Gastrointestinal Cancer) Calibrator Grade |
|||
| MBS319694-5x50KUnits | MyBiosource | 5x50KUnits | EUR 2155 |
Lung cancer with matched cancer adjacent lung tissue array |
|||
| LC481 | TissueArray | each | EUR 168 |
|
Description: Lung cancer with matched cancer adjacent lung tissue array, including pathology grade, TNM and clinical stage, 12 cases/48 cores |
|||
Human Cancer Tissue Preparation Buffer 15: Skin Cancer Cells |
|||
| 9-80038 | CHI Scientific | 1 x 100 ml | Ask for price |
CA19-9 (Cancer, Cancer antigen 19-9, CA199) (MaxLight 490) |
|||
| MBS6264019-01mL | MyBiosource | 0.1mL | EUR 1085 |
CA19-9 (Cancer, Cancer antigen 19-9, CA199) (MaxLight 490) |
|||
| MBS6264019-5x01mL | MyBiosource | 5x0.1mL | EUR 4725 |
CA19-9 (Cancer, Cancer antigen 19-9, CA199) (MaxLight 550) |
|||
| MBS6264530-01mL | MyBiosource | 0.1mL | EUR 1085 |
CA19-9 (Cancer, Cancer antigen 19-9, CA199) (MaxLight 550) |
|||
| MBS6264530-5x01mL | MyBiosource | 5x0.1mL | EUR 4725 |
CA19-9 (Cancer, Cancer antigen 19-9, CA199) (MaxLight 650) |
|||
| MBS6265041-01mL | MyBiosource | 0.1mL | EUR 1085 |
CA19-9 (Cancer, Cancer antigen 19-9, CA199) (MaxLight 650) |
|||
| MBS6265041-5x01mL | MyBiosource | 5x0.1mL | EUR 4725 |
CA19-9 (Cancer, Cancer antigen 19-9, CA199) (MaxLight 750) |
|||
| MBS6265552-01mL | MyBiosource | 0.1mL | EUR 1085 |
CA19-9 (Cancer, Cancer antigen 19-9, CA199) (MaxLight 750) |
|||
| MBS6265552-5x01mL | MyBiosource | 5x0.1mL | EUR 4725 |
CA19-9 (Cancer, Cancer antigen 19-9, CA199) (MaxLight 405) |
|||
| MBS6263508-01mL | MyBiosource | 0.1mL | EUR 1085 |
CA19-9 (Cancer, Cancer antigen 19-9, CA199) (MaxLight 405) |
|||
| MBS6263508-5x01mL | MyBiosource | 5x0.1mL | EUR 4725 |
Liver cancer with matched cancer adjacent liver tissue array |
|||
| LV1505a | TissueArray | each | EUR 258 |
|
Description: Liver cancer with matched cancer adjacent liver tissue array, including pathology grade, TNM and clinical stage, replacing LV1505 |
|||
Colon cancer tissue array with matched cancer adjacent tissue |
|||
| BC05023a | TissueArray | each | EUR 270 |
|
Description: Colon cancer tissue array with matched cancer adjacent tissue, including TNM and pathology grade, 18 cases/ 54 cores, replacing BC05023 |
|||
Colon cancer tissue array with matched cancer adjacent tissue |
|||
| CO801b | TissueArray | each | EUR 270 |
|
Description: Colon cancer tissue array with matched cancer adjacent tissue, including pathology grade, TNM and clinical stage, 40 cases/80 cores, replcing CO801a |
|||
CA125 Cancer Antigen (Ovarian Cancer) (Glycerol Free) (MaxLight 490) |
|||
| MBS6263827-01mL | MyBiosource | 0.1mL | EUR 970 |
CA125 Cancer Antigen (Ovarian Cancer) (Glycerol Free) (MaxLight 490) |
|||
| MBS6263827-5x01mL | MyBiosource | 5x0.1mL | EUR 4220 |
CA125 Cancer Antigen (Ovarian Cancer) (Glycerol Free) (MaxLight 550) |
|||
| MBS6264338-01mL | MyBiosource | 0.1mL | EUR 970 |
CA125 Cancer Antigen (Ovarian Cancer) (Glycerol Free) (MaxLight 550) |
|||
| MBS6264338-5x01mL | MyBiosource | 5x0.1mL | EUR 4220 |
CA125 Cancer Antigen (Ovarian Cancer) (Glycerol Free) (MaxLight 650) |
|||
| MBS6264849-01mL | MyBiosource | 0.1mL | EUR 970 |
CA125 Cancer Antigen (Ovarian Cancer) (Glycerol Free) (MaxLight 650) |
|||
| MBS6264849-5x01mL | MyBiosource | 5x0.1mL | EUR 4220 |
CA125 Cancer Antigen (Ovarian Cancer) (Glycerol Free) (MaxLight 750) |
|||
| MBS6265360-01mL | MyBiosource | 0.1mL | EUR 970 |
CA125 Cancer Antigen (Ovarian Cancer) (Glycerol Free) (MaxLight 750) |
|||
| MBS6265360-5x01mL | MyBiosource | 5x0.1mL | EUR 4220 |
CA125 Cancer Antigen (Ovarian Cancer) (Glycerol Free) (MaxLight 405) |
|||
| MBS6263316-01mL | MyBiosource | 0.1mL | EUR 970 |
CA125 Cancer Antigen (Ovarian Cancer) (Glycerol Free) (MaxLight 405) |
|||
| MBS6263316-5x01mL | MyBiosource | 5x0.1mL | EUR 4220 |
Breast cancer with matched cancer adjacent breast tissue array |
|||
| BR804b | TissueArray | each | EUR 306 |
|
Description: Breast cancer with matched cancer adjacent breast tissue array, including pathology grade, TNM, clinical stage and IHC markers (ER, PR, Her-2 and Ki67), 40 cases/80 cores, replacing BR804a |
|||
Cancer Antigen CA242 (Gastrointestinal Cancer) Calibrator Grade Protein |
|||
| GWB-T00229 | GenWay Biotech | 50KU | Ask for price |
Esophagus cancer with matched cancer adjacent esophagus tissue array |
|||
| ES1025 | TissueArray | each | EUR 354 |
|
Description: Esophagus cancer with matched cancer adjacent esophagus tissue array, including pathology grade, TNM and clinical stage (AJCC 8.0), 51 cases/102 cores (1.5 mm). |
|||
Breast cancer TMA |
|||
| BR602 | TissueArray | each | EUR 270 |
|
Description: Breast cancer TMA, 3 samples have matched cancer adjacent tissue samples, including pathology grade, TNM and clinical stage (reference AJCC 8th version), 57 cases/60 cores (Core Size 1.5mm), recent tear collections |
|||
Human Colon Cancer |
|||
| HS0023 | ABM | 6 Slides/Pack | EUR 160 |
Lung cancer with matched adjacent and cancer adjacent tissue array |
|||
| BC04022a | TissueArray | each | EUR 168 |
|
Description: Lung cancer with matched adjacent and cancer adjacent tissue array, including TNM, clinical stage and pathology grade, 3 cores/case, replacing BC04022 |
|||
Lung Cancer Exosome |
|||
| P141-LG | 101Bio | - | Ask for price |
Kidney cancer (CCRCC |
|||
| KD1201 | TissueArray | each | EUR 306 |
|
Description: Kidney cancer (CCRCC,PRCC,CRCC)with kidney tissue array,including ISUP Grade, TNM/Stage, 120 cases/120 cores (core size 1.0mm ), (Previous Item# is BC07115b) |
|||
Kidney cancer with matched cancer adjacent normal tissue test array |
|||
| KD241 | TissueArray | each | EUR 48 |
|
Description: Kidney cancer with matched cancer adjacent normal tissue test array, including TNM and clinical stage, 6 cases/24 cores |
|||
Kidney cancer with matched cancer adjacent normal tissue test array |
|||
| KD241a | TissueArray | each | EUR 66 |
|
Description: Kidney cancer with matched cancer adjacent normal tissue test array, including TNM and clinical stage, 6 cases/24 cores, replacing KD241 |
|||
CA125 Cancer Antigen (Ovarian Cancer) (Glycerol Free & Azide Free) (Biotin) |
|||
| MBS6120712-01mL | MyBiosource | 0.1(mL | EUR 990 |
CA125 Cancer Antigen (Ovarian Cancer) (Glycerol Free & Azide Free) (Biotin) |
|||
| MBS6120712-5x01mL | MyBiosource | 5x0.1mL | EUR 4310 |
Liver Cancer Exosome |
|||
| P141-LV | 101Bio | - | Ask for price |
Human Ovarian Cancer |
|||
| HS0046 | ABM | 6 Slides/Pack | EUR 160 |
Colon primary cancer with metastastic cancer and normal tissue array |
|||
| CO702d | TissueArray | each | EUR 270 |
|
Description: Colon primary cancer with metastastic cancer and normal tissue array, including pathology grade, TNM and clinical stage, 65 cases/69 cores, repalcing CO702c |
|||
Gall bladder cancer with matched cancer adjacent normal tissue array |
|||
| GA461a | TissueArray | each | EUR 168 |
|
Description: Gall bladder cancer with matched cancer adjacent normal tissue array, including pathology grade, TNM and clinical stage, 20 cases/46 cores (core size 1.5mm),replacing GA461 |
|||
Kidney cancer tissue array with matched cancer adjacent kidney tissue |
|||
| KD2601a | TissueArray | each | EUR 354 |
|
Description: Kidney cancer tissue array with matched cancer adjacent kidney tissue,including TNM, clinical stage and pathology grade, 65 cases/ 260 cores, replacing KD2061 |
|||
Breast Cancer Exosome |
|||
| P141-BR | 101Bio | - | Ask for price |
Kidney Cancer Exosome |
|||
| P141-KN | 101Bio | - | Ask for price |
Bladder Cancer Exosome |
|||
| P141-BL | 101Bio | - | Ask for price |
Thyroid Cancer Exosome |
|||
| P141-TH | 101Bio | - | Ask for price |
Small intestine cancer |
|||
| SM208 | TissueArray | each | EUR 546 |
|
Description: Small intestine cancer, metastatic lymph nodes and normal tissue high density tissue microarray, 69 cases/208 core, with stage and grade data |
|||
CA125 Cancer Antigen (Ovarian Cancer), Low Cross Reactivity, Calibrator Grade |
|||
| MBS651672-50KUnits | MyBiosource | 50KUnits | EUR 710 |
CA125 Cancer Antigen (Ovarian Cancer), Low Cross Reactivity, Calibrator Grade |
|||
| MBS651672-5x50KUnits | MyBiosource | 5x50KUnits | EUR 3055 |
Prostate Cancer Exosome |
|||
| P141-PR | 101Bio | - | Ask for price |
Human Esophageal Cancer |
|||
| HS0037 | ABM | 6 Slides/Pack | EUR 160 |
Human Gallbladder Cancer |
|||
| HS0030 | ABM | 6 Slides/Pack | EUR 160 |
Colorectal Cancer Exosome |
|||
| P141-CO | 101Bio | - | Ask for price |
Human Endometrioid Cancer |
|||
| HS0045 | ABM | 6 Slides/Pack | EUR 160 |
Breast cancer tissue array with cancer adjacent breast tissue as control |
|||
| BR208a | TissueArray | each | EUR 474 |
|
Description: Breast cancer tissue array with cancer adjacent breast tissue as control, including TNM, clinical stage and pathology grade, 69 cases/ 207 cores. |
|||
Kidney cancer tissue array with matched cancer adjacent tissue as control |
|||
| KD1503 | TissueArray | each | EUR 306 |
|
Description: Kidney cancer tissue array with matched cancer adjacent tissue as control, including TNM, stage and pathology grade, 50 cases/ 150 cores |
|||
Rectum cancer tissue array with matched cancer adjacent tissue as control |
|||
| RE1504 | TissueArray | each | EUR 258 |
|
Description: Rectum cancer tissue array with matched cancer adjacent tissue as control, including TNM, clinical stage and pathology grade, 50 cases/ 150 cores |
|||
Stomach cancer tissue array with matched cancer adjacent tissue as control |
|||
| ST1505 | TissueArray | each | EUR 258 |
|
Description: Stomach cancer tissue array with matched cancer adjacent tissue as control, including TNM, stage and pathology grade, 50 cases/150 cores |
|||
Pancreatic cancer tissue array with matched cancer adjacent tissue as control |
|||
| PA811 | TissueArray | each | EUR 306 |
|
Description: Pancreatic cancer tissue array with matched cancer adjacent tissue as control, including TNM, stage and pathology grade, 27 cases/ 81 cores |
|||
CAGE1 (Cancer Antigen 1, CAGE-1, Cancer/testis antigen 3, Cancer-associated gene 1 protein, CT3, CT95, CTAG3, FLJ40441, bA69L16.7) |
|||
| MBS629252-01mg | MyBiosource | 0.1mg | EUR 520 |
CAGE1 (Cancer Antigen 1, CAGE-1, Cancer/testis antigen 3, Cancer-associated gene 1 protein, CT3, CT95, CTAG3, FLJ40441, bA69L16.7) |
|||
| MBS629252-5x01mg | MyBiosource | 5x0.1mg | EUR 2185 |
Liver primary cancer and metastatic cancer tissue array (most are stage IV) |
|||
| LV1221 | TissueArray | each | EUR 336 |
|
Description: Liver primary cancer and metastatic cancer tissue array (most are stage IV), containing NAT sample, intrahepatic cholangiocarcinoma, hepatocellular carcinoma, carcinoid, adenosquamous carcinoma, mixed carcinoma, metastatic carcinoma samples, 100 cases/122 cores |
|||
Nasopharyngeal Cancer Exosome |
|||
| P141-NA | 101Bio | - | Ask for price |
Lung Cancer Exosome RNA |
|||
| P241-LG | 101Bio | - | Ask for price |
CA72-4 Cancer Antigen |
|||
| MBS651667-25KUnits | MyBiosource | 25KUnits | EUR 605 |
CA72-4 Cancer Antigen |
|||
| MBS651667-50KUnits | MyBiosource | 50KUnits | EUR 1065 |
CA72-4 Cancer Antigen |
|||
| MBS651667-5x50KUnits | MyBiosource | 5x50KUnits | EUR 4640 |
CA72-4 Cancer Antigen |
|||
| MBS651690-50KUnits | MyBiosource | 50KUnits | EUR 1235 |
CA72-4 Cancer Antigen |
|||
| MBS651690-5x50KUnits | MyBiosource | 5x50KUnits | EUR 5410 |